The Health Care M&A Monthly: Biotech Companies Go on A Holiday Shopping Spree
During the past month, M&A activity has moved at a brisk trot in the biopharmaceutical industry. Between them, the Biotechnology and Pharmaceutical sectors have posted 17 deals, better than one every other day. The combined value of these deals is impressive,...The Health Care M&A Monthly: Health Care M&A Results for The Third Quarter of 2001
A total of 174 mergers and acquisitions were announced in the health care industry during the third quarter of 2001, down 16% from the previous quarter’s 208 deals. The chart below tallies the deals by sector. The September 11 attacks on New York and Washington, along...The Health Care M&A Monthly: How Will the Market Respond in the Wake of Terrorism?
The sights and sounds of September 11, 2001 will stay burned into our minds for some time to come. On that black Tuesday, much of the country’s financial activity was suspended: the major stock exchanges closed and the M&A market ground to a virtual standstill....The Health Care M&A Monthly: A New Round of Consolidation In The Pharmaceutical Sector?
Rumors of mega-consolidations in the Pharmaceutical sector have cropped up during the past month. A number of forces may be cited behind this speculation. One of the more timely reasons for consolidation, actual or proposed, is the need to spread the high costs of...The Health Care M&A Monthly: Drug Deals Dominate M&A–
Biotech And Pharma Outspend All Other Sectors Email this article to a friend Email Editor Rarely have we seen a month in the health care merger and acquisition market where the financial results were as lopsided as May’s. Based on figures currently available, the...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
